On Feb 6, 2023, two consecutive earthquakes with magnitudes 7·8 and 7·5 occurred along the East Anatolian Fault and devastated southern Türkiye and northern Syria—a region inhabited by almost 20 million people. Numerous cities, towns, and villages were severely damaged; thousands of buildings collapsed; at least 50 000 people are thought to have died; and more than 100 000 people have been injured. Severe aftershocks have continued to affect the region and as of March 7th, bodies belonging to thousands of people remain under the rubble.
Related Posts
- [Comment] Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer
In clinical practice, advances in immunotherapy have not yet reached patients with unresectable oesophageal squamous…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
- Spleen MRS Predicts CC Radiotherapy Outcomes
KEY TAKEAWAYS The phase 2 trial aimed to assess HP [1-13C]-pyruvate MRI/MRS for evaluating spleen…
